The iron-loaded gerbil model revisited: Effects of deferoxamine and deferiprone treatment
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 139 (1) , 50-58
- https://doi.org/10.1067/mlc.2002.120364
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Safety profile of the oral iron chelator deferiprone: a multicentre studyBritish Journal of Haematology, 2000
- Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia MajorNew England Journal of Medicine, 1998
- Liver iron and fibrosis during long‐term treatment with deferiprone in Swiss thalassaemic patientsBritish Journal of Haematology, 1998
- Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded PatientsBlood, 1998
- Results of Long-Term Iron-Chelating TherapyActa Haematologica, 1996
- Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron ChelatorsBritish Journal of Haematology, 1995
- Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia MajorNew England Journal of Medicine, 1995
- Survival in Medically Treated Patients with Homozygous β-ThalassemiaNew England Journal of Medicine, 1994
- Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating siteBritish Journal of Haematology, 1993
- The Development of Hydroxypyridin‐4‐ones as Orally Active Iron ChelatorsAnnals of the New York Academy of Sciences, 1990